IRON - Disc Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$103.33
DETAILS
HIGH:
$125.00
LOW:
$80.00
MEDIAN:
$105.00
CONSENSUS:
$103.33
UPSIDE:
54.64%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0.3 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.3) |
| Operating Expenses | ||||||
| R&D Expenses | 170.6 | 96.7 | 69.3 | 33.4 | 25.2 | 28.2 |
| SG&A Expenses | 65.4 | 33.0 | 21.9 | 14.0 | 5.8 | 5.9 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | (0.3) |
| Operating Expenses | 236.0 | 129.7 | 91.1 | 47.5 | 30.9 | 33.7 |
| Operating Income | ||||||
| Operating Income | (236.0) | (129.7) | (91.1) | (47.5) | (30.9) | (34.0) |
| Interest Expense | 3.6 | 0.6 | 0 | 0 | 2.2 | 6.8 |
| Interest Income | 27.8 | 21.3 | 14.8 | 0.7 | 0.0 | 0.0 |
| Profitability | ||||||
| EBITDA | (207.9) | (108.3) | (76.2) | (47.4) | (30.9) | (33.7) |
| EBIT | (208.2) | (108.4) | (76.3) | (47.5) | (30.9) | (34.0) |
| Income Before Tax | (211.8) | (109.0) | (76.3) | (46.8) | (36.0) | (40.8) |
| Income Tax Expense | 0.4 | 0.4 | 0.1 | 0 | 0 | 0 |
| Net Income | (212.2) | (109.4) | (76.4) | (46.8) | (36.0) | (40.8) |
| Per Share Data | ||||||
| EPS (Basic) | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| EPS (Diluted) | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Shares Outstanding | 35.3 | 27.6 | 22.3 | 1.0 | 0.8 | 1.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 91.1 | 192.4 | 360.4 | 194.6 | 88.0 | 4.5 |
| Short-Term Investments | 700.0 | 297.4 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.7 | 3.7 | 0 | 0 | (0.8) | 0 |
| Total Current Assets | 803.9 | 493.6 | 365.7 | 198.5 | 90.5 | 5.1 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 2.3 | 2.3 | 2.1 | 1.6 | 1.7 | 0.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.7 | 0.8 | 0.2 | 0.1 | 0.2 | 3.0 |
| Total Non-Current Assets | 3.0 | 3.2 | 2.3 | 1.7 | 1.9 | 3.3 |
| Total Assets | 806.9 | 496.8 | 368.0 | 200.2 | 92.4 | 8.3 |
| Current Liabilities | ||||||
| Account Payables | 9.0 | 7.9 | 12.6 | 16.2 | 2.6 | 2.4 |
| Short-Term Debt | 0.6 | 0 | 0 | 0 | 5 | 16.7 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 27.0 | 7.2 | 5.8 | 3.6 | 1.4 | 0 |
| Total Current Liabilities | 36.6 | 23.3 | 21.4 | 22.6 | 13.4 | 24.9 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 1.3 | 28.3 | 0 | 0 | 0.4 | 5.0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 29.2 | 0 | 0 | 0 | 141.5 | 0.4 |
| Total Non-Current Liabilities | 30.4 | 29.9 | 1.4 | 1.0 | 143.2 | 5.3 |
| Total Liabilities | 67.1 | 53.2 | 22.9 | 23.6 | 156.6 | 30.2 |
| Stockholders' Equity | ||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (510.2) | (298.0) | (188.6) | (112.2) | (65.4) | (112.8) |
| Accumulated Other Comprehensive Income | 1.0 | 0.3 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 739.8 | 443.6 | 345.1 | 176.6 | (64.2) | (21.9) |
| Total Liabilities & Equity | 806.9 | 496.8 | 368.0 | 200.2 | 92.4 | 8.3 |
| Debt Metrics | ||||||
| Total Debt | 1.9 | 30 | 2.1 | 1.3 | 7.1 | 21.6 |
| Net Debt | (89.3) | (162.4) | (358.3) | (193.3) | (81.0) | 17.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (212.2) | (109.4) | (76.4) | (46.8) | (36.0) | (40.8) |
| Depreciation & Amortization | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | 0.3 |
| Stock-Based Compensation | 34.3 | 16.8 | 5.5 | 2.1 | 0.5 | 1.0 |
| Change in Working Capital | 3.5 | 3.2 | (3.0) | 2.1 | 1.3 | 0.3 |
| Other Non-Cash Items | (6.4) | (4.8) | 0.3 | 0.3 | 6.6 | 6.5 |
| Operating Cash Flow | (180.4) | (93.9) | (73.5) | (42.3) | (27.5) | (32.7) |
| Investing Activities | ||||||
| Capital Expenditure | (0.9) | (0.5) | (0.1) | (0.2) | (0.1) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (849.6) | (386.6) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 456.2 | 94.8 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (394.3) | (292.3) | (0.1) | (0.2) | (0.1) | (0.0) |
| Financing Activities | ||||||
| Net Debt Issuance | 0 | 29.0 | 0 | 0 | (4.6) | 14 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.6 | 2.0 | 40.3 | 95.5 | 4.7 | 0.2 |
| Financing Cash Flow | 473.4 | 218.3 | 239.4 | 149.0 | 89.9 | 34.2 |
| Cash Position | ||||||
| Net Change in Cash | (101.3) | (167.9) | 165.8 | 106.6 | 62.3 | 1.5 |
| Cash at Beginning | 192.7 | 360.6 | 194.8 | 88.2 | 25.9 | 3.3 |
| Cash at End | 91.4 | 192.7 | 360.6 | 194.8 | 88.2 | 4.8 |
| Free Cash Flow | (181.3) | (94.4) | (73.6) | (42.4) | (27.6) | (32.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.3) |
| Operating Income | (236.0) | (129.7) | (91.1) | (47.5) | (30.9) | (34.0) |
| Net Income | (212.2) | (109.4) | (76.4) | (46.8) | (36.0) | (40.8) |
| EPS (Diluted) | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Balance Sheet | ||||||
| Cash & Equivalents | 91.1 | 192.4 | 360.4 | 194.6 | 88.0 | 4.5 |
| Total Assets | 806.9 | 496.8 | 368.0 | 200.2 | 92.4 | 8.3 |
| Total Debt | 1.9 | 30 | 2.1 | 1.3 | 7.1 | 21.6 |
| Stockholders' Equity | 739.8 | 443.6 | 345.1 | 176.6 | (64.2) | (21.9) |
| Cash Flow | ||||||
| Operating Cash Flow | (180.4) | (93.9) | (73.5) | (42.3) | (27.5) | (32.7) |
| Capital Expenditure | (0.9) | (0.5) | (0.1) | (0.2) | (0.1) | (0.0) |
| Free Cash Flow | (181.3) | (94.4) | (73.6) | (42.4) | (27.6) | (32.7) |